Avsola Interactions
There are 568 drugs known to interact with Avsola (infliximab), along with 9 disease interactions. Of the total drug interactions, 305 are major, 255 are moderate, and 8 are minor.
- View all 568 medications that may interact with Avsola
- View Avsola disease interactions (9)
Most frequently checked interactions
View interaction reports for Avsola (infliximab) and the medicines listed below.
- albuterol
- aspirin
- azelastine nasal
- azithromycin
- biotin
- cetirizine
- clonazepam
- Cymbalta (duloxetine)
- escitalopram
- famotidine
- folic acid
- gabapentin
- Humira (adalimumab)
- lamotrigine
- melatonin
- meloxicam
- metformin
- methotrexate
- omeprazole
- pantoprazole
- prednisone
- propranolol
- sertraline
- tramadol
- turmeric
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
- Zyrtec (cetirizine)
Avsola disease interactions
There are 9 disease interactions with Avsola (infliximab) which include:
- heart failure
- liver disease
- infections
- malignancies
- neurologic reactions
- tuberculosis
- COPD
- hematologic abnormalities
- hepatitis B
More about Avsola (infliximab)
- Avsola consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (9)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.